Tan, W. C., Lai, R., Xiu, J. T. J., Xinli, H. T., Tan, H. S., Kay, J. C. W., Ming, D. A. J., Ng, Q. S., Kanesvaran, R. (2026). Treatment utilization in metastatic renal cell carcinoma (mRCC) following implementation of a national cancer drug list (CDL) drug reimbursement program in Singapore: A real-world single-centre study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.482